Skin Diseases  >>  Halaven (eribulin mesylate)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Halaven (eribulin mesylate) / Eisai
NCT02225470: Eribulin Versus Vinorelbine in Subjects With Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes

Completed
3
530
RoW
E7389 (Eribulin Mesylate), Vinorelbine injection
Eisai Co., Ltd.
HER2-Negative Breast Cancer, Triple Negative Breast Cancer, Breast Cancer, Cancer of Breast, Breast Tumors
09/17
06/18

Download Options